NDC:
42858-502-03
Unit Size/Quantity:
8 mg bottle (30 count)
Indication: Buprenorphine sublingual tablets contain buprenorphine, a partial opioid agonist, and are indicated for the treatment of opioid dependence and are preferred for induction.
Buprenorphine sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support.
Please see full Prescribing Information for more information.
Markings: White to off-white, round flat-faced beveled edged tablet debossed with “RP” on one side and “b8” on the other side.
Storage and Handling: Store at 20° to 25°C (68° to 77°F).
